All In MedTech

Device Trial Radar · NCT06834880

AQT90 FLEX NTproBNP2 Test Kit - 23004 - Reference Interval Study

AQT90 FLEX NTproBNP2 Test Kit - 23004 - Reference Interval Study Protocol

Last checked: Nov 19, 2026Latest source record: Aug 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

781

Actual

Start

Jan 27, 2025

Primary completion

Feb 5, 2025

Study completion Feb 5, 2025

Sponsor

Lead sponsor
Radiometer Medical ApSNot on our public-company list
Sponsor type
Industry
First posted
Feb 19, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish the overall (age- and sex independent) at least 95th percentile upper reference limit (URL) of the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.

Conditions

  • Heart Failure

Interventions

  • No intervention; Observational studyDevice

    Sample bank with Health Questionnaire

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 95th percentile of normal concentrations with 95% confidence intervals (CI) for overall samplesTime frame: Baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Radiometer Turku Oy

    Turku, Finland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.